We are proud to participate in this year's poster session with our customers, showcasing scientific findings from key research. Come visit us and see this year’s posters. Below is a preview of each one:
Comparison of blood film review rates between Atellica HEMA and ADVIA 2120i hematology analyzers
Leeds Teaching Hospitals NHS Trust, Leeds, United Kingdom
Atellica HEMA 570 and Atellica HEMA 580 analyzers were recently launched by Siemens Healthcare Diagnostics Inc. to replace their legacy ADVIA 2120i Hematology Systems. Low blood film review rates are a welcome and, increasingly, an expected feature of hematology analyzers in modern high-throughput laboratories. The purpose of this study was to compare blood film review rates between the new Atellica HEMA and our legacy ADVIA 2120i automated hematology analyzers.
Preliminary analytical performance data of a new D-dimer assay
Siemens Healthcare Diagnostics Products GmbH, Marburg, Germany
D-dimer is a global indicator of coagulation activation and fibrinolysis and an indirect marker of thrombotic activity. The major diagnostic application of D-dimer testing lies in the exclusion of thromboembolic events, such as deep vein thrombosis (DVT) or pulmonary embolism (PE) and has been implemented into corresponding guidelines. The INNOVANCE D-Dimer 2.0 assay3 for the quantitative, non-standardized determination of D-dimer was investigated for its key analytical performance characteristics on a variety of coagulation analyzers.